Guideline for Management of the Clinical T1 Renal Mass

摘要

No AccessJournal of UrologyAdult Urology1 Oct 2009Guideline for Management of the Clinical T1 Renal Massis accompanied byIncreased Tissue Factor Expression and Poor Nephroblastoma PrognosisPercutaneous Microwave Ablation or Nephrectomy for VX-2 Carcinoma in Rabbit KidneyTemporary Segmental Renal Artery Occlusion Using Reverse Phase Polymer for Bloodless Robotic Partial Nephrectomy Steven C. Campbell, Andrew C. Novick, Arie Belldegrun, Michael L. Blute, George K. Chow, Ithaar H. Derweesh, Martha M. Faraday, Jihad H. Kaouk, Raymond J. Leveillee, Surena F. Matin, Paul Russo, and Robert G. Uzzo Steven C. CampbellSteven C. Campbell Financial interest and/or other relationship with Pfizer, Sanofi Aventis, Novartis, Aventis Pharmaceuticals. More articles by this author , Andrew C. NovickAndrew C. Novick The Panel dedicates this work to Dr. Andrew Novick, who served as Chair of the Panel until his untimely death in 2008. Dr. Novick was well recognized for his contributions to renal surgery, and kidney cancer in particular. More articles by this author , Arie BelldegrunArie Belldegrun Financial interest and/or other relationship with Galil Medical, Wilex, Bayer, Pfizer, ROEI Medical, Amgen, Agensys, Hana Biosciences, Cougar Biotechnology. More articles by this author , Michael L. BluteMichael L. Blute More articles by this author , George K. ChowGeorge K. Chow More articles by this author , Ithaar H. DerweeshIthaar H. Derweesh More articles by this author , Martha M. FaradayMartha M. Faraday More articles by this author , Jihad H. KaoukJihad H. Kaouk Financial interest and/or other relationship with Endocare, Intuitive Surgical. More articles by this author , Raymond J. LeveilleeRaymond J. Leveillee Financial interest and/or other relationship with Pluromed, LMA Urology-Suisee, Boston Scientific, ACMI, Applied Medial, ValleyLab, Ethicon, Intuitive Surgical. More articles by this author , Surena F. MatinSurena F. Matin Financial interest and/or other relationship with Johnson & Johnson Wound Management. More articles by this author , Paul RussoPaul Russo Financial interest and/or other relationship with Wilex AG. More articles by this author , and Robert G. UzzoRobert G. Uzzo Financial interest and/or other relationship with Pfizer, Bayer. More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2009.07.004AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1 : Kidney. In: AJCC Cancer Staging Manual. Edited by . New York: Springer Verlag2002: 323. Google Scholar 2 : Cancer statistics, 2008. CA Cancer J Clin2008; 58: 71. Google Scholar 3 : Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev2002; 11: 171. Google Scholar 4 : Increased incidence of serendipitously discovered renal cell carcinoma. Urology1998; 51: 203. Crossref, Medline, Google Scholar 5 : Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. BJU Int2008; 68: 737. Google Scholar 6 : Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol2006; 176: 2391. Link, Google Scholar 7 : Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol2007; 178: 414. Link, Google Scholar 8 : Are small renal tumors harmless?: Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol2006; 176: 896. Link, Google Scholar 9 : National utilization trends of partial nephrectomy for renal cell carcinoma: a case of under utilization?. Urology2006; 67: 254. Google Scholar 10 : Laparoscopic nephrectomy: Initial case report. J Urol1991; 146: 278. Link, Google Scholar 11 : Open radical nephrectomy for localized renal cell carcinoma. In: Comprehensive Textbook of Genitourinary Oncology. Edited by . Philadelphia: Lippincott, Williams